Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein
KEYWORDS: people, vte, prophylaxis, risk, vte prophylaxis, surgery, lmwh, use, risk vte, pharmacological, consider, bleeding, undergoing, people undergoing, person

in NICE technology appraisal guidance for preventing venous thromboembolism in adults after elective hip replacement surgery. For full details, see the guidance on rivaroxaban (TA170, 2009). [2018] 1.11.6 Consider one of the following if none of the options in recommendation 1.11.5 can be used: • Apixaban, which is recommended as an option in NICE technology appraisal guidance for preventing venous thromboembolism in adults after elective hip replacement surgery. For full details, see the guidance on apixaban (TA245, 2012). • Dabigatran etexilate, which is recommended as an option in NICE technology appraisal guidance for preventing venous thromboembolism in adults after elective hip replacement surgery. For full details, see the guidance on dabigatran etexilate (TA157, 2008). [2018] 1.11.7 Consider anti-embolism stockings until discharge from hospital if pharmacological interventions are contraindicated in people undergoing elective hip replacement surgery. [2018] Elective knee replacement In March 2018: • the use of LMWH and rivaroxaban in young people under 18 in recommendation 1.11.8 was off label • the use of aspirin in recommendation 1.11.8 was off label • the use of apixaban and dabigatran etexilate in young people under 18 in recommendation 1.11.9 was off label. See NICE's information on prescribing medicines. 1.11.8 Offer VTE prophylaxis
